Empowered Patient Podcast

JP Milon is CEO of Paris-based Quantum Genomics, a company developing a treatment for patients with hypertension that is resistant to currently available medications.  Over-represented in populations with resistant hypertension, minorities often suffer severe complications as a result of having perpetual high blood pressure.  JP discusses firibastat, Quantum Genomic's experimental drug which works by acting on the part of the brain that lowers blood pressure and could potentially help these under-served patients. #hypertension  #cardiology  #treatmentresistance #biotech Quantum Genomics  

Anders Rabbe, CEO, Isofol Medical discusses the developments of new therapies for patients with advanced colorectal cancer, a devastating disease with limited treatment options.  Isofol is developing arfolitixorin to increase the efficacy of standard of care chemotherapy and is actively enrolling patients in a global Phase 3 clinical trial. #CRC #ColonCancer #ColorectalCancer #FightCRC #FightCancer Isofol Medical

Tony Winders, founder, The Winders Group, reports back from the recent CES show where he spent time investigating the accessibility, digital health and fitness wearables offerings.  He came away with great insights about how large consumer packaged goods companies are entering the market with products designed for consumers of all ages driven by artificial intelligence and lessons learned from early developers of smart Internet connected devices. @TonyWinders #CES2019 The Winders Group

Masha and Claire founders of Tasty High Chef are gourmet personal chefs and event planners in San Diego.  They are developing cannabis infused meals from fresh, nutritious food to address a wide variety of needs of medical cannabis users as well as to create cannabis infused dining experiences for special occasions for recreational users over 21.  This is a story of Masha's passion for using delicious food as medicine and Claire's experience as a medical researcher to create a wow experience. TastyHighChef.com

Kirby Brady, Director Research, San Diego Regional Economic Development Corp. shares recent research about the abundance of healthcare and pharmaceutical companies, research institutions, medical device developers, and artificial intelligence and big data experts that have made San Diego a world-renowned hub of precision health.  The report also reveals the number of start-ups that have been created to translate basic research into functional digital health solutions. @SDRegionalEDC PrecisionHealthSD.com  

Jesús Martin-Garcia, CEO, GeNeuro discusses the need for new treatment approaches for multiple sclerosis (MS), a long lasting, often disabling disease of the central nervous system that affects 2.5 million people worldwide.  GeNeuro is developing a potential new approach for treating disease progression, the largest unmet medical need in MS, by seeking to block mechanisms suspected of driving neurodegeneration. #MultipleSclerosis  #MS  $GNRO GeNeuro.com

Dr. Patrik De Haes, CEO, Oxurion discusses the need for new treatments for diabetic eye disease, a leading cause of blindness in people of working age worldwide.  About half of patients living with diabetic eye disease respond poorly or do not respond at all to the current standard of care.  Oxurion is working to advance its clinical development and is partnering with advocacy groups around the world to increase patients' access to potential therapies. @Oxurion Oxurion.com

Elad Kedar, CEO, Orasis discusses CSF-1, the company's corrective eye drop being developed for the treatment of presbyopia as an alternative to reading glasses.  Presbyopia, the inability to focus on near objects, is common after the age of 40 and affects more than 1.8 billion people worldwide.  While glasses have been used for hundreds of years to correct vision, ophthalmologists are excited about these innovative eye drops that will change eye care. Orasis-Pharma.com   

Dr. Chorom Pak, President and CEO, LynxBio was a finalist in the John G. Watson Quick Pitch Competition presented by the Tech Coast Angels and the San Diego Venture Group.  She talks about using an advanced approach to diagnosing cancer by using a standard-of-care biopsy to create a living model of a patient's cancer, including the patient's own microenvironment, to rapidly identify effective treatment options. @lynxbio @TCASanDiego @SDVG Lynx Biosciences

Shiv Shukla, Founder and CEO, NeuraLace Medical is a healthcare entrepreneur with a passion for finding a new treatment for managing chronic neuropathic pain and the winner of the John G. Watson Quick Pitch Competition presented by the Tech Coast Angels and San Diego Venture Group.  Their Axon Therapy is currently being tested with the VA where patients receive recurring non-invasive treatments that have dramatically reduced the need for opioids for chronic pain. #QuickPitch18 @TCASanDiego @SDVG NeuraLace Medical